C.H. v. HHS - Hepatitis B, idiopathic thrombocytopenic purpura (ITP) (2021)

On December 14, 2018, C.H., the parent of minor I.H., filed a petition for compensation alleging that the hepatitis B and inactivated polio (IPV) vaccines, administered to I.H. on March 6, 2017, caused him to develop idiopathic thrombocytopenic purpura (ITP). The petition stated that I.H. suffered residual effects from this injury for more than six months.

The respondent, the Secretary of Health and Human Services, denied that the vaccines caused I.H.'s condition. Despite the respondent's denial, the parties filed a joint stipulation agreeing to compensation.

Special Master Christian J. Moran found the stipulation reasonable and adopted it as the court's decision.

The award included a lump sum payment of $7,632.84 to reimburse a lien for services rendered by Wellcare, a Medicaid plan, payable jointly to petitioner and Equian. An additional amount was awarded to purchase an annuity contract.

These amounts represent all other damages available under the program. The decision was originally filed on November 3, 2021, and reissued on December 8, 2021.

Petitioner's counsel was Ronald C. Homer of Conway, Homer, P.C., and respondent's counsel was Ronalda E.

Kosh of the United States Department of Justice. The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or the medical experts consulted.